• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On TEVA


    Teva Pharmaceutical Industries Limited (TEVA)

    -NYSE
    58.00 Up 1.35(2.38%) Dec 19, 4:09PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 20,314,000   20,317,000   18,312,000  
    Cost of Revenue9,607,000  9,665,000  8,797,000  
    Gross Profit 10,707,000   10,652,000   9,515,000  
    Operating Expenses
    Research Development1,427,000  1,356,000  1,095,000  
    Selling General and Administrative5,319,000  5,117,000  4,410,000  
    Non Recurring2,312,000  1,974,000  901,000  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 1,649,000   2,205,000   3,109,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes1,649,000  2,205,000  3,109,000  
    Interest Expense399,000  386,000  153,000  
    Income Before Tax1,250,000  1,819,000  2,956,000  
    Income Tax Expense(43,000)(137,000)127,000  
    Minority Interest16,000  53,000  (9,000)
    Net Income From Continuing Ops1,269,000  1,963,000  2,759,000  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 1,269,000   1,963,000   2,759,000  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 1,269,000   1,963,000   2,759,000  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.